Recent advances in hematology: an update from the 16th Congress of the EHA

Abstract

The burden of hematological disorders on healthcare providers is reaching a new peak as the population continues to age, making current research and debate in hematology arguably of greater importance than ever before. At the 16th Congress of the European Hematology Association in London, UK, the latest advances in research, and their associated clinical implications, were highlighted. This article provides a brief overview of a selection of presentations taken from the extensive program.

Keywords::

• bleeding disorders
• congress
• EHA
• funding
• leukemia
• lymphoma

Financial & competing interests disclosure

Tess O’Neill is a full-time employee of Expert Reviews Ltd. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.